Peter Krippl

Peter Krippl

UNVERIFIED PROFILE

Are you Peter Krippl?   Register this Author

Register author
Peter Krippl

Peter Krippl

Publications by authors named "Peter Krippl"

Are you Peter Krippl?   Register this Author

51Publications

863Reads

33Profile Views

Austrian recommendations for the management of polycythemia vera.

Wien Klin Wochenschr 2018 Sep 19;130(17-18):535-542. Epub 2018 Jul 19.

Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-018-1359-3DOI Listing
September 2018

Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.

Wien Klin Wochenschr 2018 Sep 24;130(17-18):495-504. Epub 2018 Jul 24.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-018-1365-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132876PMC
September 2018

LOOKING BACK ON 5 YEARS OF HORIZON SCANNING IN ONCOLOGY.

Int J Technol Assess Health Care 2016 Jan 9;32(1-2):54-60. Epub 2016 Mar 9.

Ludwig Boltzmann Institute for Health Technology Assessment.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462316000052DOI Listing
January 2016

Association of vascular endothelial growth factor--a gene polymorphisms and haplotypes with breast cancer metastases.

Acta Oncol 2015 Mar 25;54(3):368-76. Epub 2014 Aug 25.

Division of Internal Medicine, GKK Outpatient Department , Graz , Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2014.948056DOI Listing
March 2015

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.

Ann Hematol 2014 Nov 21;93(11):1825-38. Epub 2014 Jun 21.

3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Hospital Salzburg, and Center for Clinical Cancer and Immunology Trials at Salzburg Cancer Research Institute, Müllner Hauptstrasse 48, 5020, Salzburg, Austria,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00277-014-2126
Web Search
http://link.springer.com/10.1007/s00277-014-2126-9
Publisher Site
http://dx.doi.org/10.1007/s00277-014-2126-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176957PMC
November 2014

Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer.

J Cancer Res Clin Oncol 2010 Dec 5;136(12):1813-9. Epub 2010 Mar 5.

Department of Internal Medicine, Division of Oncology, Medical University Graz, Auenbruggerplatz 15, 8036 Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-010-0839-2DOI Listing
December 2010

Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment.

Curr Med Res Opin 2010 Nov 17;26(11):2535-42. Epub 2010 Sep 17.

Institute of Pharmacology of Natural Compounds and Clinical Pharmacology, University Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2010.518304DOI Listing
November 2010

Long-Term Disease Control with Lapatinib and Capecitabine in a Heavily Pretreated Patient with ErbB2-Positive Metastatic Breast Cancer.

Breast Care (Basel) 2010 27;5(5):335-337. Epub 2010 Oct 27.

Universitätsklinikfür Frauenheilkunde und Geburtshilfe, Graz, Österreich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000321394DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132959PMC
October 2010

Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis.

Anticancer Res 2010 Jun;30(6):2393-7

Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, A-8036 Graz, Austria.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/30/6/2393.full.pdf
Web Search
June 2010

Association of interleukin-10 gene variation with breast cancer prognosis.

Breast Cancer Res Treat 2010 Feb 13;119(3):701-5. Epub 2009 May 13.

Division of Oncology, Department of Internal Medicine, Medical University Graz, Austria, Auenbruggerplatz 15, 8036, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-009-0417-yDOI Listing
February 2010

Integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk.

Int J Colorectal Dis 2009 Feb 3;24(2):159-63. Epub 2008 Oct 3.

Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00384-008-0587-9DOI Listing
February 2009

Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.

Eur J Cancer 2008 Jul 29;44(11):1572-6. Epub 2008 May 29.

Department of Therapeutic Radiology and Oncology, Medical University of Graz, Auenbruggerplatz 32, 8036 Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2008.04.021DOI Listing
July 2008

Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk.

J Cancer Res Clin Oncol 2008 May 16;134(5):591-5. Epub 2007 Oct 16.

Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-007-0322-xDOI Listing
May 2008

A multigenic approach to predict breast cancer risk.

Breast Cancer Res Treat 2007 Aug 21;104(2):159-64. Epub 2006 Oct 21.

Department of Internal Medicine, Division of Oncology, Medical University Graz, Auenbruggerplatz 15, 8036 Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-006-9408-4DOI Listing
August 2007

Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.

Eur J Cancer 2007 Feb 19;43(3):472-5. Epub 2006 Dec 19.

Department of Therapeutic Radiology and Oncology, Medical University of Graz, Auenbruggerplatz 32, 8036 Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2006.11.003DOI Listing
February 2007

Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40.

Orphanet J Rare Dis 2006 Nov 7;1:44. Epub 2006 Nov 7.

Department of Pulmonology, University Clinic of Internal Medicine, Medical University Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1750-1172-1-44DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1664552PMC
November 2006

Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors.

Cancer 2006 Jul;107(1):193-200

Department of Internal Medicine, Division of Oncology, Medical University of Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21910DOI Listing
July 2006

Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.

Breast Cancer Res Treat 2006 May;97(1):67-72

Department of Internal Medicine, Division of Oncology, Medical University Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-005-9089-4DOI Listing
May 2006

Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendation.

BMC Cancer 2006 Jan 4;6. Epub 2006 Jan 4.

Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-6-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1334209PMC
January 2006

Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk.

Breast Cancer Res Treat 2005 Mar;90(2):113-5

Department of Internal Medicine, Division of Oncology, Medical University Graz, Auenbruggerplatz 15, 8036, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-004-3607-7DOI Listing
March 2005

Genetic variants of the sulfotransferase 1A1 and breast cancer risk.

Breast Cancer Res Treat 2004 Sep;87(1):19-22

Department of Internal Medicine, Division of Oncology, Medical University Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/B:BREA.0000041574.90735.eaDOI Listing
September 2004

Margins in extra-abdominal desmoid tumors: a comparative analysis.

J Surg Oncol 2004 Jun;86(3):152-6

Department of Orthopedic Surgery, Medical University Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.20057DOI Listing
June 2004

The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.

Clin Cancer Res 2004 May;10(10):3518-20

Department of Internal Medicine, Division of Oncology, Medical University Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-0010DOI Listing
May 2004

The 825C>T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer.

Cancer Lett 2004 Mar;206(1):59-62

Department of Internal Medicine, Division of Oncology, Karl-Franzens-University, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2003.11.030DOI Listing
March 2004

The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer.

Breast Cancer Res Treat 2003 Dec;82(3):165-8

Department of Internal Medicine, Division of Oncology, Karl-Franzens University Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/B:BREA.0000004372.20461.33DOI Listing
December 2003

The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk.

Cancer Lett 2003 Nov;201(2):181-4

Department of Internal Medicine, Division of Oncology, Karl-Franzens-University, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0304-3835(03)00468-3DOI Listing
November 2003

A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.

Int J Cancer 2003 Sep;106(4):468-71

Department of Internal Medicine, Division of Oncology, Karl-Franzens University Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.11238DOI Listing
September 2003

The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk.

Breast Cancer Res Treat 2003 Sep;81(2):169-72

Department of Internal Medicine, Division of Oncology, Karl-Franzens University Graz, Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/A:1025752420309DOI Listing
September 2003

Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy.

Breast Cancer Res Treat 2003 Jun;79(3):347-53

Department of Obstetrics & Gynecology, General Hospital Lainz, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1024016508925DOI Listing
June 2003